Fundraising Fox

Myla Lai-Goldman

Investor

Venture Partner at Hatteras Venture Partners · Founder & Chair at GeneCentric

Burlington, Vermont

Writes $100K – $5M checks · typically $1.5M

Find your path to Myla

113 people in our graph share verified history with Myla — schools, employers, funds. One of them is your warm intro.

Andrew ArmourunlockedMyla: together at University of Pennsylvania (1976–1979)
×4Myla: together at University of Pennsylvania
×2Myla: together at Hatteras Venture Partners
×2Myla: together at Columbia University Vagelos College of Physicians and Surgeons

About

Myla Lai-Goldman is Chair and Co-Founder of GeneCentric Therapeutics, Inc. and serves as a Board Member at Mercy BioAnalytics, Inc. She spent over 18 years at LabCorp, including 10 years as Executive Vice President, Chief Medical Officer and Chief Scientific Officer, where she oversaw three genomic laboratories and led the introduction of more than 400 clinical assays. She holds a BS from the University of Pennsylvania and an MD from Columbia University College of Physicians and Surgeons, and is board-certified in anatomic and clinical pathology.

Contact· self-published, not guessed

Founder & Chair at GeneCentric

Intro paths

→

In turn, Myla can intro founders to GeneCentric's investors below.

GeneCentric's investors · 2

Hatteras Venture PartnersResearch Triangle · $500K – $4M checks · since 2025IAG Capital PartnersCharleston

Co-founders at GeneCentric

CMCharles M. Perou
Charles M. PerouFounder and Director

Experience

  1. Mercy BioAnalytics, Inc.Board Membercurrent2023 — present
  2. NovoPathBoard Membercurrent2022 — present
  3. GeneCentric Therapeutics, Inc.Co-Founder and Chaircurrent2021 — present
  4. GeneCentric Therapeutics, Inc.Executive Chair2019 — 2021Research Triangle Park, NC
  5. GeneCentric Therapeutics, Inc.Chief Executive Officer2011 — 2018280 S. Mangum Street Suite 350 Durham, NC 27701
  6. West Pharmaceutical ServicesBoard Membercurrent2014 — present
  7. Hatteras Venture PartnersVenture Partnercurrent2011 — present280 S Mangum St, Suite 350 Durham, NC 27701
  8. Personalized Science, LLCManaging Partnercurrent2009 — presentS Burlington, Vermont
  9. QuanterixBoard Member2025 — 2026
  10. Hitachi High-Tech America, Inc.Scientific Advisory Board Member2023 — 2026
  11. Akoya Biosciences, Inc.Board Member2021 — 2025
  12. LabCorpExecutive VP, CMO & CSO1998 — 2008128 East Maple Avenue, Burlington, NC 27215
  13. LabCorpPathologist, VP, SVP1990 — 1998

Skills & more

Strategy7Diagnostics2Hardware Diagnostics31Infectious Diseases13Biotechnology46Oncology34Personalized Medicine8Genomics8Lifesciences30Cancer7Commercialization38Immunology11
+12 moreMolecular BiologyClinical DevelopmentDrug DevelopmentTechnology TransferDrug DiscoveryPharmaceutical IndustryBiopharmaceuticalsHealthcareGeneticsBiochemistryMedical DevicesClinical Trials

From Myla's professional profile.

Investments

Board seats

GeneCentric

Per SEC Form D filings.

Colleagues at Hatteras Venture Partners

Alston Gardner
Special Advisor at Hatteras Venture Partners
Ben Scruggs
Partner at Hatteras Venture Partners
Ben Scruggs, PhD
Partner at Hatteras Venture Partners
Christy Shaffer
General Partner at Hatteras Venture Partners
Christy Shaffer, PhD
General Partner at Hatteras Venture Partners
Clay Thorp
General Partner at Hatteras Venture Partners
Declan Devens
Operations Analyst at Hatteras Venture Partners
Douglas Reed
General Partner at Hatteras Venture Partners

Frequently asked questions

Who is Myla Lai-Goldman?
Myla Lai-Goldman is Chair and Co-Founder of GeneCentric Therapeutics, Inc. and serves as a Board Member at Mercy BioAnalytics, Inc. She spent over 18 years at LabCorp, including 10 years as Executive Vice President, Chief Medical Officer and Chief Scientific Officer, where she oversaw three genomic laboratories and led the introduction of more than 400 clinical assays. She holds a BS from the University of Pennsylvania and an MD from Columbia University College of Physicians and Surgeons, and is board-certified in anatomic and clinical pathology.
Where does Myla Lai-Goldman work?
Myla Lai-Goldman is Venture Partner at Hatteras Venture Partners and Founder & Chair at GeneCentric.
What check size does Myla Lai-Goldman write?
Myla Lai-Goldman typically writes checks of $100K – $5M.
What boards does Myla Lai-Goldman sit on?
Myla Lai-Goldman holds tracked board seats at GeneCentric.
Where did Myla Lai-Goldman go to school?
Myla Lai-Goldman studied at Columbia University Vagelos College of Physicians and Surgeons (Doctor of Medicine (MD)); University of Pennsylvania (Bachelor of Arts (B.A.), Biology).

Founder mafias

Columbia University Vagelos College of Physicians and Surgeons mafia15

Also came through, then founded or led a company.

Kevin M. SlawinM.D.Founded Phoenix SENOLYTIX +4Robin Berzin MDMDFounded Cureatr +1Joseph MayerDoctor of Medicine (M.D.)Founded CureatrJonathan GertlerMDFounded OptivioBijan SalehizadehMDFounded AledadeAdam RegelmannMDFounded Quartzy

+ 8 more

Labcorp mafia5

Also came through, then founded or led a company.

Seth RainfordRegional Vice President & General ManagerFounded Digital DiagnosticsMark RothLaboratory TechnologistFounded LighthouseSam AngiuoliHead of Bioinformatics and Data Science, PGDxFounded Personal Genome DiagnosticsSuneer JainMolecular Oncology SupervisorFounded SUN GENOMICS

Hatteras Venture Partners mafia4

Also came through, then founded or led a company.

Ben ScruggsPrincipalFounded Altis BiosystemsMalcolm KendallPartnerFounded Microbiome Insights Inc.Heather MadsenOperating PartnerFounded PIPr Therapeutics

Mercy BioAnalytics mafia2

Also came through, then founded or led a company.

Sarah KalilAdvisorFounded CoreMap

Quanterix mafia2

Also came through, then founded or led a company.

David R. WaltDirectorFounded Sherlock Biosciences +3

Same school

Also attended Columbia University Vagelos College of Physicians and Surgeons29

Tristan HuntPartner at Averin CapitalDeborah PalestrantPartner, Executive Chair, 4:59 Initiative at 5AM VenturesShreeram AradhyeInvestor at Novartis Venture FundJoseph MayerPartner at HLM Investment PartnersJoan LaRovereOperating Partner at iSelect FundCurt LaBelleVenture Partner at Adjuvant Capital

+ 23 more

Also attended University of Pennsylvania1,302

Brian ActonCo-founder of WhatsApp; co-founder of Signal FoundationKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalDasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC Partners

+ 1,296 more

Shared employers

Also worked at Mercy BioAnalytics, Inc.3

Stan LapidusCEO, SynapDX & Founding Pillar at Pillar VCSarah KalilExecutive Officer at Boston MicrofluidicsPaul BlavinCo-Founder & Vice Chairman at Mercy BioAnalytics

Also worked at West Pharmaceutical Services2

Morgan JanesAssociate at JDRF T1D FundVladimir WalkoBusiness Development Officer at Signet Healthcare Partners

Also worked at Akoya Biosciences, Inc.4

Deval LashkariSenior Partner at Telegraph Hill PartnersRob HartPartner at Telegraph Hill PartnersRobert SheplerPartner Emeritus at Telegraph Hill PartnersJack FuchsCo-Founder and Operating Partner at Blackhorn Ventures

Also worked at LabCorp15

Ricardo HerediaAssociate / Fellow at Mendoza VenturesRichelle ParhamObvious Champion at Obvious VenturesSeth RainfordCo-Founder, Digital Diagnostics at Tribes VenturesGarheng KongInvestor at HealthQuest CapitalAndrew HallVenture Partner at Iter InvestmentsValerie B. PalmieriExecutive Officer, Director at Aspira Women's Health

+ 9 more